Patents by Inventor Andrew C. Paoletti

Andrew C. Paoletti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
    Patent number: 12253529
    Abstract: The invention generally relates to methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders, and associated processes. Specifically, the present invention is directed toward methods to determine prognosis, diagnosis or efficacy of a therapeutic regimen by using a detectable label to measure levels of alpha-synuclein.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: March 18, 2025
    Assignee: C2N Diagnostics
    Inventors: Tim West, Andrew C. Paoletti
  • METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISEASES, DISORDERS AND ASSOCIATED PROCESSES
    Publication number: 20190204344
    Abstract: The invention generally relates to methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders, and associated processes. Specifically, the present invention is directed toward methods to determine prognosis, diagnosis or efficacy of a therapeutic regimen by using a detectable label to measure levels of alpha-synuclein.
    Type: Application
    Filed: February 20, 2019
    Publication date: July 4, 2019
    Inventors: Tim West, Andrew C. Paoletti
  • Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
    Patent number: 10261097
    Abstract: The invention generally relates to methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders, and associated processes. Specifically, the present invention is directed toward methods to determine prognosis, diagnosis or efficacy of a therapeutic regimen by using a detectable label to measure levels of alpha-synuclein.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: April 16, 2019
    Assignee: C2N Diagnostics
    Inventors: Tim West, Andrew C. Paoletti
  • Methods for the Diagnosis and Treatment of Neurological and Neurodegenerative Diseases, Disorders and Associated Processes
    Publication number: 20160313353
    Abstract: The invention generally relates to methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders, and associated processes. Specifically, the present invention is directed toward methods to determine prognosis, diagnosis or efficacy of a therapeutic regimen by using a detectable label to measure levels of alpha-synuclein.
    Type: Application
    Filed: June 9, 2016
    Publication date: October 27, 2016
    Inventors: Tim West, Andrew C. Paoletti
  • Methods for the Diagnosis and Treatment of Neurological and Neurodegenerative Diseases, Disorders and Associated Processes
    Publication number: 20140349308
    Abstract: Methods for the diagnosis, prognosis, treatment and determining the efficacy of a therapeutic regimen for neurological and neurodegenerative diseases, disorders, and associated processes include using a detectable label to measure levels of alpha-synuclein.
    Type: Application
    Filed: September 19, 2012
    Publication date: November 27, 2014
    Inventors: Tim West, Andrew C. Paoletti